First Eagle Investment Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-60,000
| Closed | -$347K | – | 359 |
|
2016
Q2 | $347K | Sell |
60,000
-319,727
| -84% | -$1.85M | ﹤0.01% | 277 |
|
2016
Q1 | $2.3M | Buy |
379,727
+179,727
| +90% | +$1.09M | 0.01% | 199 |
|
2015
Q4 | $1.83M | Hold |
200,000
| – | – | ﹤0.01% | 203 |
|
2015
Q3 | $1.13M | Buy |
+200,000
| New | +$1.13M | ﹤0.01% | 217 |
|
2015
Q2 | – | Sell |
-559,780
| Closed | -$8.78M | – | 321 |
|
2015
Q1 | $8.78M | Hold |
559,780
| – | – | 0.02% | 165 |
|
2014
Q4 | $8.51M | Buy |
559,780
+23,400
| +4% | +$356K | 0.02% | 165 |
|
2014
Q3 | $5.79M | Hold |
536,380
| – | – | 0.01% | 182 |
|
2014
Q2 | $8.19M | Buy |
536,380
+136,380
| +34% | +$2.08M | 0.02% | 178 |
|
2014
Q1 | $7.23M | Sell |
400,000
-447,550
| -53% | -$8.09M | 0.02% | 154 |
|
2013
Q4 | $11.8M | Hold |
847,550
| – | – | 0.03% | 140 |
|
2013
Q3 | $8.88M | Buy |
847,550
+423,200
| +100% | +$4.43M | 0.03% | 160 |
|
2013
Q2 | $3.31M | Buy |
+424,350
| New | +$3.31M | 0.01% | 208 |
|